Skip to main content

Advertisement

Log in

Radiosurgery of Liver Tumors: Value of Robotic Radiosurgical Device to Treat Liver Tumors

  • Radiation Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The treatment of isolated liver metastases has become a rapidly developing field with many new, technically advanced methods. Here we present the therapeutic efficacy of a robotic radiosurgery for local control of liver metastases from solid tumors.

Methods

Patients with tumorous lesions to the liver, not qualifying for surgery, were treated with single-session radiosurgery (24 Gy) that used robotic image-guided real-time tumor tracking. All detectable lesions had to be irradiated. In a prospective analysis, follow-up was performed by magnetic resonance imaging scanning 2 months after the treatment, and subsequently at 3-month intervals to evaluate local control. For inclusion into the radiosurgery treatment protocol, tumor volumes had to be <90 ml.

Results

Thirty-six patients (median age, 65 years) with a total of 54 target lesions were evaluated. Single lesions were treated in 23 patients and multiple targets in 13 patients. Metastases originated from colon cancer (n = 19), ovarian cancer (n = 3), pancreatic cancer (n = 2), breast cancer (n = 2), and others (n = 6). Four lesions were of primary liver origin (hepatocellular carcinoma and cholangiocellular carcinoma). Median tumor volume was 18 ml (range, 2.2–90 ml). The median follow-up was 21.3 months. The disease of 25 patients (69.4%) showed complete or partial local response, 6 patients (16.7%) had stable lesions, and 5 patients (14%) experienced local recurrence. Grade 2–4 adverse events due to radiation treatment were not observed.

Conclusions

Robotic radiosurgery with image-guided real-time tumor tracking of liver neoplasm is a new and promising approach for patients with disease that is not eligible for surgical resection and might enhance the possibilities of multidisciplinary oncological treatment concepts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238:871–83.

    Article  PubMed  Google Scholar 

  2. Shah SA, Bromberg R, Coates A, et al. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg. 2007;205:676–83.

    Article  PubMed  Google Scholar 

  3. McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control. 2006;13:32–41.

    PubMed  Google Scholar 

  4. Small R, Lubezky N, Ben-Haim M. Current controversies in the surgical management of colorectal cancer metastases to the liver. Isr Med Assoc J. 2007;9:742–7.

    PubMed  Google Scholar 

  5. Dawood O, Mahadevan A, Goodman KA. Stereotactic body radiation therapy for liver metastases. Eur J Cancer. 2009;45:2947–59.

    Article  PubMed  Google Scholar 

  6. Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 2006;45:823–30.

    Article  PubMed  Google Scholar 

  7. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27:1572–8.

    Article  PubMed  Google Scholar 

  8. Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 2006;45:838–47.

    Article  PubMed  Google Scholar 

  9. Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I–II study. Acta Oncol. 2006;45:831–7.

    Article  PubMed  Google Scholar 

  10. Lartigau E, Mirabel X, Prevost B, et al. Extracranial stereotactic radiotherapy: preliminary results with the CyberKnife. Onkologie. 2009;32:209–15.

    Article  PubMed  Google Scholar 

  11. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89:276–84.

    Article  CAS  PubMed  Google Scholar 

  12. Howard JH, Tzeng CW, Smith JK, et al. Radiofrequency ablation for unresectable tumors of the liver. Am Surg. 2008;74:594–600.

    PubMed  Google Scholar 

  13. Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008;15:2757–64.

    Article  PubMed  Google Scholar 

  14. Vogl TJ, Straub R, Eichler K, et al. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy—local tumor control rate and survival data. Radiology. 2004;230:450–8.

    Article  PubMed  Google Scholar 

  15. Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol. 2005;15:279–83.

    Article  PubMed  Google Scholar 

  16. Stubbs R, Wickremesekera S. Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases. HPB (Oxford). 2004;6:133–9.

    CAS  Google Scholar 

  17. Pech M, Mohnike K, Wieners G, et al. Radiotherapy of liver metastases: comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol. 2008;184:256–61.

    Article  PubMed  Google Scholar 

  18. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001;19:164–70.

    CAS  PubMed  Google Scholar 

  19. Herfarth KK, Hof H, Bahner ML, et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys. 2003;57:444–51.

    Article  PubMed  Google Scholar 

  20. Veltri A, Sacchetto P, Tosetti I, et al. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol. 2008;31:948–56.

    Article  PubMed  Google Scholar 

  21. Muacevic A, Drexler C, Wowra B, et al. Technical description, phantom accuracy, and clinical feasibility for single-session lung radiosurgery using robotic image-guided real-time respiratory tumor tracking. Technol Cancer Res Treat. 2007;6:321–8.

    CAS  PubMed  Google Scholar 

  22. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008;112:650–8.

    Article  PubMed  Google Scholar 

  23. Tai A, Erickson B, Li XA. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation. Int J Radiat Oncol Biol Phys. 2009;74:283–9.

    PubMed  Google Scholar 

  24. Kirkpatrick JP, Brenner DJ, Orton CG. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Med Phys. 2009;36:3381–4.

    Article  PubMed  Google Scholar 

  25. Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–52.

    PubMed  Google Scholar 

  26. Katz AW, Elsaleh H, Dawson LA, Schell MC. A phase I trial of highly conformal radiation therapy for patients with liver metastases—RTOG0438. 2005.

  27. King CR, Lehmann J, Adler JR, Hai J. CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat. 2003;2:25–30.

    PubMed  Google Scholar 

  28. Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838–46.

    Article  CAS  PubMed  Google Scholar 

  29. Farrell RJ, Smiddy PF, Pilkington RM, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol. 1999;30:580–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest Statement

The authors state that they have no conflicts of interest with Accuray Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastian Stintzing MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stintzing, S., Hoffmann, RT., Heinemann, V. et al. Radiosurgery of Liver Tumors: Value of Robotic Radiosurgical Device to Treat Liver Tumors. Ann Surg Oncol 17, 2877–2883 (2010). https://doi.org/10.1245/s10434-010-1187-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1187-9

Keywords

Navigation